Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

Share Price is delayed by 15 minutes
Get Live Data
177.00    0.00 (0.00%)
Bid:
174.00
Ask:
180.00
Spread: 6.00 (3.448%)
Market Cap: £3.28m
NBB Live PriceLast checked at - London Stock Exchange

Intraday Norman Broadb Share Chart

Issue of Equity

14 Nov 2022 07:00

RNS Number : 2058G
Norman Broadbent PLC
14 November 2022
 

14 November 2022

 

Norman Broadbent plc

(the "Company")

 

Issue of Equity,

 Director/PDMR shareholding

and

Total Voting Rights

 

Norman Broadbent plc (AIM: NBB), a leading quoted Executive Search and Interim Management firm offering a diversified portfolio of integrated Leadership Acquisition & Advisory Services, announces that it has issued 1,076,753 new ordinary shares of 1p each ("New Shares") at 3.75 pence per New Share to an executive director of the Company ("Director"), certain Persons Discharging Managerial Responsibilities ("PDMRs") and certain employees in lieu of part of their annual cash bonus.

 

Application has been made to the London Stock Exchange for the New Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission and dealings in the New Shares will occur at 8.00 a.m. on 18 November 2022. The New Shares will be issued credited as fully paid and rank in full for all dividends and other distributions declared, made or paid after Admission and will otherwise be identical to and rank pari passu in all respects with the existing ordinary shares of 1p each in the capital of the Company ("Ordinary Shares"). 

 

Director/PDMR shareholding

As set out above, a Director, certain PDMRs and certain employees have been issued New Shares, details of which are set out below:

 

 

 

 

 

 

 

 

Name

 

 

 

 

 

 

Position held

 

 

Number of New Shares issued in lieu of part of annual cash bonus

 

Number of Ordinary Shares held immediately following Admission

 

 

 

 

Percentage of the Company's enlarged share capital held immediately following Admission

Kevin Davidson

CEO

161,333

419,219

0.68%

Sean Buchan

COO1

158,400

158,400

0.26%

John Begley

PDMR

187,953

195,362

0.32%

Michael Diamond

PDMR

158,400

308,400

0.50%

Certain employees

-

410,667

410,667

0.66%

Total

 

1,076,753

 

 

1 On 24 August 2022, Sean Buchan was appointed as the Company's COO, a non-Board role. Previously, Steve Smith, the Company's CFO, had also been the COO

 

Total Voting Rights

Immediately following Admission, the Company will have 61,817,510 Ordinary Shares in issue, none of which will be held in treasury. Accordingly, shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Peter Searle, Non-Executive Chairman of the Company, commented:

"I am delighted that certain members of the team have chosen to take New Shares in lieu of part of their annual cash bonus thereby demonstrating their continued commitment to the Company's growth and increase in shareholder value."

 

 

For further Information, please contact:

Norman Broadbent plc       020 7484 0000

Peter Searle, Chairman

Kevin Davidson, CEO

Steve Smith, CFO

 

Shore Capital        020 7408 4090

Nominated Adviser and Broker

Tom Griffiths / Tom Knibbs (Corporate Advisory)

Henry Willcocks (Corporate Broking)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEQFLFFLFLZFBX
Date   Source Headline
20th May 202610:40 amRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
8th May 20267:00 amRNSDirectorate Change
28th Apr 20265:25 pmRNSCourt Approval of Capital Reduction
22nd Apr 20267:00 amRNSPosting of Annual Report & Notice of AGM
21st Apr 20267:00 amRNSQ1 2026 Trading Update
20th Apr 20267:00 amRNSDirectorate Change
31st Mar 20269:11 amRNSTotal Voting Rights
26th Mar 20262:00 pmRNSResult of General Meeting
25th Mar 20267:00 amRNSFinal Results
18th Mar 20268:00 amRNSHolding(s) in Company
10th Mar 20267:00 amRNSProposed Capital Reduction
9th Mar 20269:23 amRNSReplacement- Results Notice/Investor Presentation
9th Mar 20267:00 amRNSNotice of Interim Results & Investor Presentation
25th Feb 20267:00 amRNSAcquisition And Total Voting Rights
6th Feb 20267:03 amRNSDirectorate Change
21st Jan 20267:00 amRNSDirectorate Change
15th Jan 20267:00 amRNSQ4 and FY25 Trading Update
13th Oct 20257:00 amRNSQ3 2025 Trading Update
9th Sep 20257:00 amRNSChange of Auditor
8th Sep 20257:00 amRNSInterim Results
19th Aug 20257:00 amRNSNotice of Interim Results & Investor Presentation
11th Aug 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
10th Jul 20257:00 amRNSH1 2025 Trading Update
19th Jun 20252:49 pmRNSNotification of major holdings
19th Jun 20257:00 amRNSDirector/PDMR Shareholding
16th Jun 20257:00 amRNSDirector/PDMR Shareholding
22nd May 202512:58 pmRNSResult of AGM, Capital Reorganisation and TVR
22nd May 20257:00 amRNSAGM Statement
22nd Apr 20257:00 amRNSPosting of ARA & Notice of AGM
2nd Apr 20257:00 amRNSQ1 2025 Trading Update and Final Results
4th Mar 20257:00 amRNSNotice of Results & Investor Presentation
16th Jan 20257:00 amRNSTrading Update
16th Oct 20247:00 amRNSQ3 2024 Trading Update
11th Oct 20244:00 pmRNSDirector/PDMR shareholding
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
3rd Oct 20247:00 amRNSChange of Registered Office
9th Sep 20247:00 amRNSInterim Results
19th Aug 20247:00 amRNSNotice of Interim Results & Investor Presentation
22nd Jul 20243:46 pmRNSNotification of major holdings
11th Jul 20247:00 amRNSH1 2024 Trading Update
23rd May 20245:29 pmRNSResult of Annual General Meeting
25th Apr 20247:00 amRNSQ1 2024 Trading Update
24th Apr 20247:00 amRNSSmall Cap Awards nomination
15th Apr 20243:18 pmRNSNotification of major holdings
8th Apr 202412:11 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20244:01 pmRNSNotification of major holdings
28th Mar 20247:00 amRNSPosting of ARA & Notice of AGM
27th Mar 20247:00 amRNSFinal Results
26th Mar 20244:07 pmRNSNotification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.